Bioxcel Therapeutics Inc (BTAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -59,599 | -179,053 | -165,757 | -106,931 | -82,169 |
| Depreciation Amortization | 309 | 318 | 327 | 297 | 188 |
| Accounts receivable | -60 | 177 | -248 | N/A | N/A |
| Other Working Capital | -5,723 | 2,306 | 10,674 | 4,980 | 1,020 |
| Other Operating Activity | -6,954 | 21,246 | 19,663 | 19,501 | 14,611 |
| Operating Cash Flow | $-72,027 | $-155,006 | $-135,341 | $-82,153 | $-66,350 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -20 | -139 | -445 | -316 |
| Investing Cash Flow | $N/A | $-20 | $-139 | $-445 | $-316 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 98,600 | N/A | N/A |
| Common Stock Issued | 39,688 | 27,540 | 283 | 102,447 | 256,383 |
| Other Financing Activity | -3,028 | -1,018 | -2,646 | 0 | -9,024 |
| Financing Cash Flow | $36,660 | $26,522 | $96,237 | $102,447 | $247,359 |
| Beginning Cash Position | 65,221 | 193,725 | 232,968 | 213,119 | 32,426 |
| End Cash Position | 29,854 | 65,221 | 193,725 | 232,968 | 213,119 |
| Net Cash Flow | $-35,367 | $-128,504 | $-39,243 | $19,849 | $180,693 |
| Free Cash Flow | |||||
| Operating Cash Flow | -72,027 | -155,006 | -135,341 | -82,153 | -66,350 |
| Capital Expenditure | 0 | -20 | -139 | -445 | -316 |
| Free Cash Flow | -72,027 | -155,026 | -135,480 | -82,598 | -66,666 |